英派斯2025年中报简析：增收不增利，公司应收账款体量较大

Core Viewpoint - The recent financial report of Yingpais (002899) shows a slight increase in total revenue but a significant decline in net profit, indicating potential challenges in profitability and cash flow management [1][3]. Financial Performance - Total revenue for the first half of 2025 reached 574 million yuan, a year-on-year increase of 0.47% [1]. - Net profit attributable to shareholders was 31.67 million yuan, down 38.09% compared to the previous year [1]. - In Q2 2025, total revenue was 284 million yuan, reflecting a decline of 14.87% year-on-year [1]. - Q2 net profit was 17.48 million yuan, a decrease of 53.1% year-on-year [1]. - Gross margin decreased to 26.72%, down 11.98% year-on-year, while net margin fell to 5.51%, down 38.38% year-on-year [1]. - Total expenses (selling, administrative, and financial) amounted to 80.26 million yuan, accounting for 13.97% of revenue, an increase of 11.46% year-on-year [1]. Balance Sheet and Cash Flow - The company reported a significant increase in accounts receivable, which reached 213 million yuan, representing 195.33% of the net profit [1][3]. - Cash and cash equivalents decreased to 361 million yuan, down 43.18% year-on-year [1]. - Interest-bearing liabilities were reported at 702 million yuan, a decrease of 8.12% year-on-year [1]. - Earnings per share (EPS) dropped to 0.22 yuan, a decline of 45% year-on-year, while operating cash flow per share increased to 0.35 yuan, up 89.22% year-on-year [1]. Investment Insights - The company's return on invested capital (ROIC) was 5.7%, indicating average capital returns [3]. - Analysts project a net profit of 116 million yuan for 2025, with an average EPS forecast of 0.78 yuan [3]. - The company’s business model relies heavily on capital expenditures, necessitating careful evaluation of capital projects and their financial viability [3]. Fund Holdings - The largest fund holding Yingpais is Tianhong Medical Health Mixed A, with 1.479 million shares, showing an increase in holdings [4]. - Other funds have also increased their positions or newly entered the top ten holdings, indicating growing interest in the company [4].